Cite
KRT17 Accelerates Cell Proliferative and Invasive Potential of Laryngeal Squamous Cell Carcinoma (LSCC) through Regulating AKT/mTOR and Wnt/β-Catenin Pathways.
MLA
Wang, JianQiu, et al. “KRT17 Accelerates Cell Proliferative and Invasive Potential of Laryngeal Squamous Cell Carcinoma (LSCC) through Regulating AKT/MTOR and Wnt/β-Catenin Pathways.” Evidence-Based Complementary & Alternative Medicine (ECAM), Oct. 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1155/2022/6176043.
APA
Wang, J., Lan, L., Ma, B., Ren, G., & Yin, C. (2022). KRT17 Accelerates Cell Proliferative and Invasive Potential of Laryngeal Squamous Cell Carcinoma (LSCC) through Regulating AKT/mTOR and Wnt/β-Catenin Pathways. Evidence-Based Complementary & Alternative Medicine (ECAM), 1–11. https://doi.org/10.1155/2022/6176043
Chicago
Wang, JianQiu, Longjiang Lan, Bingliang Ma, Gang Ren, and ChengYi Yin. 2022. “KRT17 Accelerates Cell Proliferative and Invasive Potential of Laryngeal Squamous Cell Carcinoma (LSCC) through Regulating AKT/MTOR and Wnt/β-Catenin Pathways.” Evidence-Based Complementary & Alternative Medicine (ECAM), October, 1–11. doi:10.1155/2022/6176043.